September 14, 2021
Article
The investigators noted that heart attacks are often caused by the rupturing of vulnerable plaques, defined as plaques with a large lipid core with a thin fibrous cap that serves as a wall or barrier around the plaque to keep it intact.
Pharmacists should stay knowledgeable about recommendations and evidence related to therapies.
September 09, 2021
Empagliflozin demonstrated a 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalization for heart failure, compared with placebo.
September 08, 2021
Although the cardiovascular condition was thought to be benign, the disease could put pregnant women at greater risk for serious complications during childbirth.
Bleeding in the upper GI tract is among the most common bleeding complications following acute myocardial infarction, causing considerable suffering and increasing the risk of death.
September 07, 2021
Treatment-emergent serious adverse events were reported more frequently in patients with PVD, which was likely due to their more advanced disease, according to the researchers.
September 02, 2021
Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease, and 17% less likely to develop heart failure.
September 01, 2021
Published results indicate that marriage, urban living put people less at risk for cardiovascular problems.
Because patients may interact with a pharmacist more regularly than other health care providers, it is possible to detect potential signs and symptoms of atrial fibrillation in a patient during their encounters.
August 31, 2021
The AHA worked with a team of leading health authorities to develop the advisory, which highlights recommendations, algorithms, and guidance for health care professionals and researchers who specialize in heart and brain health.
